Aug. 19–20, 2019 • Seattle
ORGANIZERS:Lisa H. Butterfield, PhD – Parker Institute for Cancer Immunotherapy/University of California San FranciscoMary L. Disis, MD, FACP – University of WashingtonOlivera J. Finn, PhD – University of Pittsburgh Kristen Hege, MD – Celgene Corporation/University of California San FranciscoElizabeth M. Jaffee, MD – Sidney Kimmel Cancer Center – Jefferson HealthSolange Peters, MD, PhD – Centre Hospitalier Universitaire VaudoisPadmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer CenterThe Women in Cancer Immunotherapy Network (WIN) is a Society for Immunotherapy of Cancer initiative seeking to promote and elevate women in the cancer immunotherapy field. An initiative championed by SITC Immediate Past President Lisa H. Butterfield, PhD, the society's first female president, the network includes programs that provide a forum for women to discuss important topics relevant to their advancement in the field.The SITC Women in Cancer Immunotherapy Network (WIN) Leadership Institute (View Schedule), scheduled for Aug. 19–20, 2019, in Seattle, is a free, one-and-a-half day program organized by female luminaries in the cancer immunotherapy field that seeks to empower emerging female leaders in the field.The institute will explore topics relevant to women, including:
The WIN Leadership Institute will feature presentations from experienced female leaders, panel discussions allowing participants to ask questions and interact with these leaders and informal networking opportunities throughout the program.The application process is now closed. Thank you for applying for the Women in Cancer Immunotherapy Network (WIN) Leadership Institute. Applicants have been notified of their acceptance status.This program is supported in part by grants from Bristol-Myers Squibb, Genentech, Incyte Corporation, Merck & Co., Inc., and Pfizer, Inc. (as of July 11, 2019)
Available to SITC members, the WIN is creating a database that can be used to better identify female experts to engage in society activities. The network is seeking women interested in presenting data, speaking at meetings, serving as subject matter experts, conducting article reviews for the Journal for ImmunoTherapy of Cancer (JITC), serving as meeting chairs, co-chairs, organizers, and more. Female SITC members are asked to sign up for this opportunity via the SITC Volunteer Pool to indicate your interest and be included in this database. SITC will use this information to better ensure balanced representation in all society activities. Please join now to be a part of this exciting effort within the society.If you have questions about the database, please contact Senior Administrative Manager, Rosanne Stelpflug.
SITC Professional Interest Communities are an original series of online communities created exclusively for SITC members. Within these communities, researchers and clinicians in the cancer immunotherapy field expand their network and receive career development support from colleagues.The Women in SITC Community is open to women who share a common interest in immunology and cancer. Open to professional women, the goal of the community is to increase females in leadership roles within the society, foster connections and working opportunities among members, discuss immunotherapy toxicities (open to other specialties that deal with toxicity of immunotherapy), create mentorship opportunities, discuss gender bias and professional opportunities and contributions to the field of oncology/immunotherapy.Not a member? Join SITC today and gain immediate access to the Women in SITC Community!
On Friday, Nov. 9, 2018, SITC hosted its second-annual Women in Cancer Immunotherapy Reception.Held during the society's 33rd Annual Meeting & Pre-Conference Programs (SITC 2018), the event was a continuation of an effort by the society to connect female professionals in the cancer immunotherapy field to network and discuss important issues they are facing.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org